| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Reproductive Sciences Program (N.D, K.M.B, H.J.B, M.B., E.A.Y., F.J.K.), Departments of Physiology (K.M.B., F.J.K.), Mental Health Research Institute (E.A.Y.), University of Michigan, Ann Arbor, Michigan 48109-0404; and Animal and Food Sciences Division (G.K.B.), Lincoln University, Canterbury 8150, New Zealand
Address all correspondence and requests for reprints to: Fred J. Karsch, Reproductive Sciences Program, University of Michigan, 300 North Ingalls Building, Room 1101 Southwest, Ann Arbor, Michigan 48109-0404. E-mail: fjkarsch{at}umich.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In the present study, we tested the hypothesis that cortisol mediates the inhibitory effects of endotoxin on pulsatile GnRH and LH secretion in sheep, a model species in which the secretory profiles and temporal associations of GnRH and LH can be monitored with high resolution. We employed two approaches. First, we delivered cortisol in the absence of an endotoxin challenge to determine if a cortisol rise, similar to that induced by endotoxin, is sufficient to suppress pulsatile LH secretion. Second, we suppressed cortisol synthesis during an endotoxin challenge to determine if increased secretion of cortisol is necessary for suppression of pulsatile LH and GnRH secretion.
| Materials and Methods |
|---|
|
|
|---|
General experimental design
This study consisted of five experiments. Because the rationale and designs of later experiments were based on results of the initial ones, experimental design details are presented in Results. Due to their sequential nature, the experiments spanned both the breeding and anestrous seasons. Each individual experiment contained both control and experimental treatments. Thus, all experiments could be interpreted independently. The following procedures are generally applicable.
One day before each experiment, ewes were penned individually in the same room or in groups of three, and indwelling jugular catheters were inserted for sampling peripheral blood. In two of the five experiments, pituitary portal blood was collected by continuous withdrawal using a technique described in detail by Caraty et al. (23). For this purpose, a sampling apparatus was surgically implanted into the hypophyseal region. The sheep were then allowed to recover and pituitary portal blood was collected 2 wk later. This procedure allows pituitary portal and peripheral blood to be sampled at frequent intervals from animals that are not anesthetized, sedated, or physiologically compromised. Ewes were provided with hay and water during portal blood collection.
Treatments
Cortisol (hydrocortisone sodium phosphate, aqueous solution, 50 mg/ml; Merck and Co., West Point, PA) suspended in sesame oil vehicle or vehicle alone was injected sc. Cortisol doses were determined in pilot studies to increase the serum cortisol concentration within the range of values observed in ewes during endotoxin challenge (
60150 ng/ml). Endotoxin (Escherichia coli lipopolysaccharide, Serotype 055:B5; Sigma, St. Louis, MO) was dissolved in nonpyrogenic saline (10 µg/ml) and injected iv at either 40 or 400 ng/kg. Both doses induce fever, inhibit reproductive neuroendocrine function, stimulate the neuroendocrine stress axis, and provoke transient sickness behaviors to varying degrees (e.g. lethargy, labored breathing, and diarrhea) (11, 12). Metyrapone in capsules (Ciba-Geigy, Basel, Switzerland) was used to inhibit cortisol synthesis. This drug, which blocks the 11-ß hydroxylase enzyme necessary for cortisol synthesis, has been found to be effective in sheep (24). For use, metyrapone was removed from the capsules and administered as seven hourly injections at a dose of 11.3 mg/kg, im. This dose was based on that used in humans (25); pilot studies in our laboratory confirmed that it inhibits endotoxin-induced cortisol secretion in ewes without evoking overt adverse side effects. Vehicle for metyrapone consisted of an aqueous solution containing 10% polyethylene glycol/10% glycerol/1% gelatin. Progesterone was administered sc by implanting one 50 x 75-mm SILASTIC brand (Dow Corning, Midland, MI) packet that produces an early luteal phase level of serum progesterone (
1 ng/ml) in ovariectomized ewes (26).
Hormone assays
LH was measured in duplicate aliquots of plasma (10200 µl) using a modification (27) of a previously described RIA (28, 29). Values are expressed in terms of NIH-LH-S12. Mean intra- and interassay coefficients of variation (CV) were 6.4% and 8.0%, respectively, and assay sensitivity for 200-µl aliquots averaged 0.8 ng/ml (37 assays). Cortisol was measured in duplicate 50-µl aliquots of plasma using the Coat-a-Count kit (Diagnostic Products Corp., Los Angeles, CA), previously validated for use in sheep (12). Mean intra- and interassay CV were 3.5% and 8.0%, respectively, and assay sensitivity averaged 0.8 ng/ml (15 assays). Progesterone was determined in duplicate 100 µl aliquots using the Coat-a-Count progesterone assay kit (Diagnostic Products Corp.), previously validated for use in sheep (30). Intra- and interassay CV were 6.1% and 9.0%, respectively, and assay sensitivity averaged 0.05 ng/ml (14 assays). GnRH was measured in duplicate in methanol extracts of approximately 200 µl aliquots of portal plasma using a previously described RIA (31, 32). Intra- and interassay variation averaged 10.2% and 14.6%, respectively, and assay sensitivity averaged 0.16 pg/ml (six assays).
To assay 11-desoxycortisol, the ImmuChem double antibody 11-desoxycortisol assay kit (ICN Pharmaceuticals, Inc., Costa Mesa, CA) was modified by adding 10 µl charcoal-stripped plasma to standard curve and control tubes. The assay was validated for use in sheep. Assay specificity was checked by confirming parallelism between serial dilutions of ovine samples and 11-desoxycortisol standards. Recovery averaged 103% when assay buffer was spiked with known amounts of standard (ICN Pharmaceuticals, Inc.). Samples from ovariectomized ewes not treated with endotoxin produced values at or below assay sensitivity (0.2 ng/ml). Concentrations of 11-desoxycortisol in samples were determined in duplicate 10-µl aliquots of plasma diluted 1:10 in charcoal-stripped plasma from ovariectomized ewes. All samples were measured in a single assay. Mean intraassay CV was 11.1%, and assay sensitivity averaged 0.2 ng/ml.
Data analysis
LH and GnRH pulses were identified using the Cluster pulse detection algorithm (33). Cluster sizes for peaks and nadirs were defined as 1 and 2 for LH, and 1 and 1 for GnRH. The t-statistic used to identify a significant increase and decrease was 2.6 and 2.6 for LH, and 3.8 and 3.8 for GnRH. LH and GnRH pulse amplitudes were defined as the difference between the peak of a pulse and its preceding nadir. Total pulsatile LH and GnRH outputs were calculated as the product of the number of pulses x mean pulse amplitude. GnRH in pituitary portal blood was calculated as a collection rate (pg/min) rather than concentration. This minimizes errors due to contamination of portal samples with peripheral blood or cerebrospinal fluid (both judged to be negligible in this study), or due to changes in the rate of portal blood flow.
Before statistical analysis, plasma hormone concentrations were log transformed and pulse frequencies were square root transformed to normalize variability across a broad range of values. All experiments consisted of a baseline period when no treatment was given and one or more periods when treatments were applied. To identify treatment effects, mean values for baseline and treatment periods were obtained in every ewe for each parameter (e.g. plasma cortisol, LH pulse measures, core body temperature, etc.). Next, a two-way, repeated-measures ANOVA (treatment x time) was used to identify significant interactions for all parameters between the control and experimental groups. ANOVAs for LH parameters excluded data during the first hour after treatment to allow time for treatments to take effect; values were also omitted for 1 h pretreatment to equalize the pre/posttreatment duration for analysis. When a significant treatment by time interaction was observed, post hoc analysis was conducted to identify specific treatment effects. This consisted of paired t tests comparing pre vs. posttreatment values in experiments 25, in which the same ewes received two treatments (control and experimental) in a cross-over design. Post hoc analysis in experiment 1, in which each ewe received three treatments, consisted of successively excluding data from one treatment and repeating the ANOVA on the remaining two. Significance level was set at P
0.05.
| Results |
|---|
|
|
|---|
During the vehicle run of the experiment, serum cortisol remained at a basal concentration (7.2 ± 1.6 ng/ml; Fig. 1A
). The low dose of cortisol elevated the mean serum cortisol concentration to approximately 60 ng/ml during hours 24 of treatment (Fig. 1B
). This increment is similar to that observed in response to a low dose of endotoxin (40 ng/kg), which inhibits pulsatile LH secretion primarily by suppressing pituitary responsiveness to GnRH (Ref. 15 ; see also experiment 4 below). The high dose of cortisol produced a serum cortisol increment to approximately 160 ng/ml (Fig. 1C
). This is similar to the increase in circulating cortisol observed in response to a high dose of endotoxin (400 ng/kg), which inhibits pulsatile GnRH release as well as pituitary responsiveness to GnRH (Refs. 12 and 15 ; see also experiments 2 and 5 below). After the 4-h treatment period, cortisol declined toward pretreatment values.
|
0.01), due to a lowering of total pulse output (39%, P
0.05) and a tendency for decreased pulse amplitude (42%, P
0.1) but not frequency. The high dose of cortisol produced a more pronounced suppression of mean LH (45%, P
0.001) due to significant suppressions of both LH pulse frequency (12%, P
0.05) and total pulse output (65%, P
0.05), and again a tendency for reduced pulse amplitude (56%, P
0.1).
|
|
Time courses for all the parameters in a representative ewe during both the vehicle and metyrapone runs are illustrated in Fig. 3A
; mean (± SEM) values for all five ewes are presented in Fig. 3B
. Two-way repeated measures ANOVA indicated endotoxin stimulated plasma cortisol (P
0.001), 11-desoxycortisol (P
0.001), progesterone (P
0.01), and core body temperature (P
0.001). Metyrapone suppressed this stimulation of cortisol (values postendotoxin 84.2 ± 9.2 vs. 16.8 ± 3.1 ng/ml for vehicle and metyrapone groups, respectively, P
0.001). Nevertheless, the mean plasma cortisol concentration postendotoxin in the metyrapone group exceeded the pretreatment baseline (6.5 ± 0.1, P
0.05). Metyrapone enhanced endotoxin-induced stimulation of 11-desoxycortisol (P
0.001) and progesterone (P
0.05), but it did not affect the generation of fever.
|
0.05), total pulsatile LH output (47%, P
0.05), and LH pulse frequency (45%, P
0.01; summary of LH results in Table 2
|
|
To test whether cortisol mediates the pituitary effect of endotoxin, we took advantage of our prior finding that a low dose of endotoxin suppresses LH pulses in ovariectomized ewes primarily by inhibiting pituitary responsiveness to GnRH (15). This experiment was conducted in two parts. Part 1 tested whether metyrapone reverses the inhibitory effect of low-dose endotoxin on LH pulses; part 2 was a terminal experiment on these same ewes to confirm that a low dose of endotoxin suppresses LH pulses independent of a reduction in GnRH secretion.
Part 1.
This experiment was conducted on 6 ovariectomized ewes, five of which had been treated with the high dose of endotoxin in experiment 2. Each ewe was treated with a low dose of endotoxin (40 ng/kg, iv bolus) plus metyrapone or endotoxin plus vehicle using a cross-over design (same protocol as in experiment 2). Jugular blood was sampled at 6-min intervals, more frequently than experiment 2 because this study was done in the late breeding season (December) when LH pulse frequency in ovariectomized ewes is near its annual maximum (35). Core body temperature was monitored at 10-min intervals.
Time courses for all parameters during both the vehicle and metyrapone runs of the experiment are illustrated in Fig. 4A
for a representative ewe. Mean values (± SEM) for all animals are presented in Fig. 4B
. As in experiment 2, endotoxin stimulated (P
0.001) plasma cortisol, although to a lesser extent than did the higher dose of endotoxin, and this response was suppressed by metyrapone (P
0.001). Furthermore, the low dose of endotoxin induced a significant rise in progesterone (P
0.001), which was enhanced by metyrapone (P
0.001), and induced fever.
|
0.01), total pulsatile LH output (29%, P
0.01), and LH pulse amplitude (28%, P
0.01) but not frequency. Metyrapone did not alter any of these suppressive effects of endotoxin.
|
The low dose of endotoxin did not significantly alter any aspect of GnRH pulsatility: mean value, pulse frequency, pulse amplitude or total pulse output (Fig. 5
, same representative ewe as in part 1; Table 4
, bottom, composite results). In contrast, this treatment significantly inhibited the mean plasma LH concentration (P
0.05) and total pulsatile LH output (P
0.01). Of particular interest relative to a pituitary effect, nearly half of the GnRH pulses after low-dose endotoxin were not accompanied by an identified LH pulse (compare GnRH with LH pulse frequency pre- vs. postendotoxin in Table 4
, part 2; see also Fig. 5A
). This reinforces the prior conclusion (15) that the low dose of endotoxin suppresses LH primarily at the level of the pituitary gland.
|
The time courses of GnRH, LH and cortisol in a representative vehicle and metyrapone-treated ewe are shown in Fig. 6A
; mean values for all ewes are presented in Fig. 6B
. As in experiment 2, endotoxin stimulated plasma cortisol (P
0.001) and metyrapone suppressed this response (P
0.001). Further, metyrapone enhanced endotoxin-induced progesterone secretion (P
0.001) but did not affect induction of fever (data not shown).
|
0.05), total GnRH/LH pulsatile output (P
0.01), and GnRH/LH pulse amplitude (P
0.001) Table 5
0.01, Table 5
|
| Discussion |
|---|
|
|
|---|
In the present study, we used endotoxin as a model of immune/inflammatory stress to test the hypothesis that enhanced secretion of cortisol mediates stress-induced suppression of pulsatile GnRH and LH secretion in the ovariectomized ewe. Prior work in ewes indicates a high dose of endotoxin (e.g. 400 ng/kg) inhibits reproductive neuroendocrine activity at both the hypothalamus and pituitary gland, whereas endotoxin at a low doses (e.g. 40 ng/kg) inhibits LH pulses without altering GnRH release, suggesting some of its effects are exerted at the pituitary (12, 15). The present study confirmed these observations. Here, we used both high and low doses of endotoxin and two complementary experimental approaches to test for a role of cortisol. One approach was to mimic the cortisol response to each of the two doses of endotoxin, but in the absence of endotoxin. The other approach was to block the cortisol rise in the face of endotoxin challenge (both doses) and determine if suppression of GnRH/LH pulses could be reversed.
In experiment 1, we delivered two doses of cortisol in the absence of endotoxin, producing plasma cortisol increments that approximated those induced by endotoxin. Both increments in circulating cortisol unambiguously suppressed pulsatile LH secretion. The smaller increment, which approximated the cortisol response to a low dose of endotoxin (40 ng/kg), suppressed the mean plasma LH concentration by 28%, which was equivalent to the 28% reduction produced by the low dose of endotoxin. The larger cortisol increment approximated the cortisol response to a higher dose of endotoxin (400 ng/kg) and caused greater suppression in the mean serum LH concentration (45%), which was comparable to that produced by the higher dose of endotoxin (40%). It should be noted that this experiment was conducted during the anestrous season when responsiveness to ovarian steroid negative feedback is greater than during the breeding season (35). Although a systematic test for a seasonal difference in responsiveness to cortisol has not yet been performed, we have found that both increments in plasma cortisol tested in experiment 1 inhibit LH pulses during the breeding season (Breen, K. M., and F. J. Karsch, unpublished observations).
The above findings clearly indicate that an acute increase in circulating cortisol itself is sufficient to inhibit pulsatile LH secretion, and that this may contribute to endotoxin-induced suppression of reproductive neuroendocrine activity in the ovariectomized ewe. To our knowledge, this is the first report that a stress-like level of cortisol can inhibit pulsatile LH secretion acutely, with suppression becoming evident within 12 h (see Fig. 1
). Further, from the effects on LH pulse frequency and amplitude, it is tempting to speculate that cortisol, like endotoxin, might exert a dose-dependent inhibition at both the hypothalamic and pituitary levels. Although further experiments are needed, using preparations in which GnRH secretion and pituitary responsiveness are assessed directly, this possibility is consistent with interpretations of prior studies in sheep and other species, including rodents and primates (20, 21, 37, 38).
Our second approach for testing a mediatory role of cortisol was to inhibit the cortisol response in the presence of an endotoxin challenge. For this purpose, we used metyrapone to block the 11-ß hydroxylase enzyme that catalyzes conversion of 11-desoxycortisol to cortisol. Suppression of the increase in cortisol failed to prevent or even attenuate the inhibitory effects of endotoxin on any aspect of LH pulsatility (experiment 2). Follow-up experiments suggested enhanced secretion of cortisol is not needed for endotoxin to suppress either hypothalamic GnRH secretion or pituitary responsiveness to GnRH (experiments 4 and 5). It should be pointed out, however, that endotoxin-induced cortisol synthesis was not totally eliminated by metyrapone. For example, in experiment 2, the mean serum cortisol concentration increased from a basal value of 616 ng/ml following endotoxin in ewes treated with metyrapone. Although far less than the endotoxin-induced increment in circulating cortisol in the absence of metyrapone, which often exceeds 100 ng/ml, it is possible that this small rise in cortisol was sufficient to suppress GnRH and LH pulses. In a recent dose-response study, however, we observed that a rise in plasma cortisol to 16 ng/ml is below the threshold needed to suppress LH pulsatility in the ovariectomized ewe (Breen, K. M., and F. J. Karsch, unpublished observations). Our findings, therefore, provide strong evidence that increased cortisol secretion is not essential for endotoxin to suppress reproductive neuroendocrine activity.
Of interest, metyrapone enhanced the endotoxin-induced secretion of biosynthetic precursors for cortisol, progesterone, and 11-desoxycortisol. This probably reflected a spilling over of these intermediates into the circulation as they began to accumulate in the adrenal cortex consequent to the blockade of 11-ß hydroxylase. It is unlikely, however, that these intermediates could account for suppressed GnRH or LH pulsatility in the absence of a typical cortisol response. The precursor 11-desoxycortisol is not considered to be biologically active (41) and the rise in circulating progesterone, in itself, was not of sufficient magnitude or duration to suppress LH pulses (experiment 3). Although it remains possible that heightened secretion of other precursors suppressed gonadotropin secretion in metyrapone-treated ewes, the more likely explanation is that adrenal steroids are not obligatory mediators of endotoxin-induced suppression of GnRH and LH pulses.
Collectively, our findings lead to the conclusion that enhanced secretion of cortisol is sufficient to suppress pulsatile LH secretion but this is not necessary for suppressive effects of endotoxin on reproductive neuroendocrine function in the ovariectomized ewe. It is important to integrate these seemingly paradoxical findings into a unified model to explain how endotoxin suppresses GnRH and LH secretion and, in particular, the role played by cortisol. One attractive model is that multiple inhibitory pathways are called into play by this immune/inflammatory stress and, in the absence of any one pathway, others effectively suppress gonadotropin secretion. In this regard, endotoxin elicits widespread pathophysiological responses and homeostatic adaptations (7). Other responses of neuroendocrine significance are enhanced production of proinflammatory cytokines, endogenous opioids, prostaglandins, and other intermediates, all of which have been implicated in the endotoxin-induced suppression of reproductive neuroendocrine function (for reviews see Refs. 2 , 6 , and 42). It seems likely, therefore, that these mediators are sufficient to inhibit gonadotropin secretion during immune/inflammatory stress. A cortisol-mediated pathway may ensure reproductive suppression during immune stress and, in addition, participate in gonadotropin suppression during any type of stressful encounter that activates the hypothalamo-pituitary-adrenal axis. These interpretations fit nicely with the concept that different types of stress activate different pathways to suppress reproductive neuroendocrine function (see review by Tilbrook et al., Ref. 40).
In considering this interpretation, however, it is important to keep in mind that our studies were conducted in ovariectomized ewes. Others have shown that the inhibitory effects of cortisol on LH secretion are intensified by estradiol (21, 22, 39). Thus, in the presence of the ovaries, cortisol may play a more dominant role in endotoxin-induced suppression of reproductive neuroendocrine function. Another possibility is that cortisol-induced inhibition of LH may be blocked during an immune challenge. In this regard, endotoxin, acting via cytokines, may reduce glucocorticoid binding or the number of available binding sites in cells that mediate cortisol inhibition of LH secretion (43, 44).
Finally, beyond the issue of whether cortisol contributes to endotoxin-induced suppression of gonadotropin secretion, it is important to place our findings into a broader physiological context by considering their relevance to the disruptive effects of stress on the estrous cycle. Of considerable interest is the recent finding that infusion of cortisol, which produced a serum cortisol increment similar to that achieved by our low dose of cortisol, interrupted the follicular phase rise in estradiol, blocked the preovulatory LH surge and disrupted the estrous cycle of the ewe (45). In sheep, as in other species, high frequency LH pulses are needed to stimulate the follicular phase increase in estradiol secretion (46). Thus, it will be of keen interest to determine if the suppressive effects of cortisol on pulsatile LH secretion, as observed in the present study, contributes to stress-induced disruption of ovarian cyclicity.
| Acknowledgments |
|---|
| Footnotes |
|---|
This work was supported by NIH-HD-30773 and the Office of the Vice President for Research at the University of Michigan. N.B. was supported by la Fondation pour la Recherche Médicale (SE000738-01) (France).
1 Present address: UMR868, Elevage des Ruminants en Régions Chaudes, 2 place P, Viala, 34060 Montpellier Cedex 1, France. ![]()
Abbreviation: CV, Coefficient of variation.
Received March 11, 2002.
Accepted for publication June 4, 2002.
| References |
|---|
|
|
|---|
-induced decrease in luteinizing hormone secretion in the ovariectomized rhesus monkey. Endocrinology 131:153158
, reduces glucocorticoid receptors translocation and function. Endocrinology 140:43594366This article has been cited by other articles:
![]() |
A. E. Oakley, K. M. Breen, A. J. Tilbrook, E. R. Wagenmaker, and F. J. Karsch Role of Estradiol in Cortisol-Induced Reduction of Luteinizing Hormone Pulse Frequency Endocrinology, June 1, 2009; 150(6): 2775 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Wagenmaker, K. M. Breen, A. E. Oakley, B. N. Pierce, A. J. Tilbrook, A. I. Turner, and F. J. Karsch Cortisol Interferes with the Estradiol-Induced Surge of Luteinizing Hormone in the Ewe Biol Reprod, March 1, 2009; 80(3): 458 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Wagenmaker, K. M. Breen, A. E. Oakley, A. J. Tilbrook, and F. J. Karsch Psychosocial Stress Inhibits Amplitude of Gonadotropin-Releasing Hormone Pulses Independent of Cortisol Action on the Type II Glucocorticoid Receptor Endocrinology, February 1, 2009; 150(2): 762 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Oakley, K. M. Breen, I. J. Clarke, F. J. Karsch, E. R. Wagenmaker, and A. J. Tilbrook Cortisol Reduces Gonadotropin-Releasing Hormone Pulse Frequency in Follicular Phase Ewes: Influence of Ovarian Steroids Endocrinology, January 1, 2009; 150(1): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen, T. L. Davis, L. C. Doro, T. M. Nett, A. E. Oakley, V. Padmanabhan, L. A. Rispoli, E. R. Wagenmaker, and F. J. Karsch Insight into the Neuroendocrine Site and Cellular Mechanism by which Cortisol Suppresses Pituitary Responsiveness to Gonadotropin-Releasing Hormone Endocrinology, February 1, 2008; 149(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen, A. E. Oakley, A. V. Pytiak, A. J. Tilbrook, E. R. Wagenmaker, and F. J. Karsch Does Cortisol Acting Via the Type II Glucocorticoid Receptor Mediate Suppression of Pulsatile Luteinizing Hormone Secretion in Response to Psychosocial Stress? Endocrinology, April 1, 2007; 148(4): 1882 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stackpole, I. J. Clarke, K. M. Breen, A. I. Turner, F. J. Karsch, and A. J. Tilbrook Sex Difference in the Suppressive Effect of Cortisol on Pulsatile Secretion of Luteinizing Hormone in Sheep Endocrinology, December 1, 2006; 147(12): 5921 - 5931. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Maeda and H. Tsukamura The impact of stress on reproduction: are glucocorticoids inhibitory or protective to gonadotropin secretion? Endocrinology, March 1, 2006; 147(3): 1085 - 1086. [Full Text] [PDF] |
||||
![]() |
T. Matsuwaki, Y. Kayasuga, K. Yamanouchi, and M. Nishihara Maintenance of Gonadotropin Secretion by Glucocorticoids under Stress Conditions through the Inhibition of Prostaglandin Synthesis in the Brain Endocrinology, March 1, 2006; 147(3): 1087 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen and F. J. Karsch Does Season Alter Responsiveness of the Reproductive Neuroendocrine Axis to the Suppressive Actions of Cortisol in Ovariectomized Ewes? Biol Reprod, January 1, 2006; 74(1): 41 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Daniel, T. H. Elsasser, A. Martinez, B. Steele, B. K. Whitlock, and J. L. Sartin Interleukin-1{beta} and tumor necrosis factor-{alpha} mediation of endotoxin action on growth hormone Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E650 - E657. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Becker, A. P. Arnold, K. J. Berkley, J. D. Blaustein, L. A. Eckel, E. Hampson, J. P. Herman, S. Marts, W. Sadee, M. Steiner, et al. Strategies and Methods for Research on Sex Differences in Brain and Behavior Endocrinology, April 1, 2005; 146(4): 1650 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen, H. J. Billings, E. R. Wagenmaker, E. W. Wessinger, and F. J. Karsch Endocrine Basis for Disruptive Effects of Cortisol on Preovulatory Events Endocrinology, April 1, 2005; 146(4): 2107 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen, C. A. Stackpole, I. J. Clarke, A. V. Pytiak, A. J. Tilbrook, E. R. Wagenmaker, E. A. Young, and F. J. Karsch Does the Type II Glucocorticoid Receptor Mediate Cortisol-Induced Suppression in Pituitary Responsiveness to Gonadotropin-Releasing Hormone? Endocrinology, June 1, 2004; 145(6): 2739 - 2746. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pitteloud, J. Villegas, A. A. Dwyer, W. F. Crowley Jr., M. J. McPhaul, and F. J. Hayes Acute Stress Masking the Biochemical Phenotype of Partial Androgen Insensitivity Syndrome in a Patient with a Novel Mutation in the Androgen Receptor J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1053 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen and F. J. Karsch Does Cortisol Inhibit Pulsatile Luteinizing Hormone Secretion at the Hypothalamic or Pituitary Level? Endocrinology, February 1, 2004; 145(2): 692 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Breen, H. J. Billings, N. Debus, and F. J. Karsch Endotoxin Inhibits the Surge Secretion of Gonadotropin-Releasing Hormone via a Prostaglandin-Independent Pathway Endocrinology, January 1, 2004; 145(1): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanobe and Y. Hayakawa Hypothalamic Interleukin-1{beta} and Tumor Necrosis Factor-{alpha}, But Not Interleukin-6, Mediate the Endotoxin-Induced Suppression of the Reproductive Axis in Rats Endocrinology, November 1, 2003; 144(11): 4868 - 4875. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuwaki, E. Watanabe, M. Suzuki, K. Yamanouchi, and M. Nishihara Glucocorticoid Maintains Pulsatile Secretion of Luteinizing Hormone under Infectious Stress Condition Endocrinology, August 1, 2003; 144(8): 3477 - 3482. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |